Analyst Ratings for Israel Chemicals Ltd. (ICL)

Updated: 2017-07-28

Analysts covering Israel Chemicals Ltd. (NYSE:ICL) have given it a consensus rating of Hold. About 30 days ago, ICL was issued an average rating of Hold.

1 analysts declared ICL a buy, 0 gave an overweight rating, 7 gave a hold rating, 1 issued an underweight rating, and 0 issued a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 0.

ICL was given price targets by several analysts. The maximum price target given was 20, implying a possible profit of 314.94 percent. The most pessimistic price target was 15.17, implying potential capital losses of 214.73 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

Analysts have revised their earnings estimates downwards for this quarter, by about -28.06 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is -30.56 percent. Meanwhile, fiscal year estimates have been revised downwards by -6.58 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of -15.8 percent in FY estimates.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, which can be compared to the 3 analysts that decreased their estimates. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, while 3 analysts made negative revisions to their fiscal year's estimates.

In the last 52-weeks, ICL has achieved a high of 4.95 and a low of 3.52. Currently the stock is 36.93 percent higher than its low, and 2.63 percent lower than its 52-week high. ICL has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The ICL value stock report compares ICL to some of its peers using value stock charts. The market cap of ICL is $21.55 billion. ICL's next earnings release will be on 0000-00-00, which is days away.